An Extension of SKY-0515 in Participants With Huntington's Disease

Summary

The goal of this clinical trial is to test if the drug SKY-0515, an oral medication, can lower harmful proteins linked to Huntington's Disease (HD) and improve the symptoms of participants with HD. This study includes men and women aged 25 and older who have HD confirmed by genetic testing and meet certain requirements for physical ability and independence.

Timeline

Start

2026-04-10

Primary completion

2029-12

Completion

2029-12

Drugs

Indications